Can a 4-Month TB regimen work as well as 6 months?
NCT ID NCT06153069
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether people with asymptomatic tuberculosis (TB) can be treated effectively with a shorter course of standard antibiotics—17 weeks instead of the usual 6 months. Researchers will compare the shorter regimen to standard treatment in 426 participants in China. The goal is to see if the shorter course can achieve similar cure rates without increasing the risk of relapse.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- isoniazid, rifampicin, pyrazinamide, ethambutol, rifapentine, moxifloxacin
- What this could lead to
- If successful, this could shorten tuberculosis treatment from the standard 6 months to about 4 months, making it easier for patients to complete therapy and reducing the burden on healthcare systems.
- What could go wrong
- This is a Phase 4 trial, but it focuses on asymptomatic TB, which is less studied. Shorter treatment may increase relapse risk, and results may not apply to symptomatic TB or other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASYMPTOMATIC TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Chest Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Huashan Hospital of Fudan University
ACTIVE_NOT_RECRUITINGShanghai, Shanghai Municipality, 200040, China
-
Liupanshui City Third People's Hospital
RECRUITINGLiupanshui, Guizhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nayong County People's Hospital
RECRUITINGNayong, Guizhou, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First People's Hospital of Linping District, Hangzhou
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could inhaled TB drugs curb the spread of Drug-Resistant tuberculosis?
- Can new tests predict who will develop active TB?
- Could a 3-Month TB cocktail replace the standard 6-Month regimen?
- Could a simple blood test ensure the right TB dose for kids?
- Community-Driven TB screening aims to reach vulnerable immigrants
- New TB vaccine aims to prevent active lung disease in adults